Clinical Trial Update: Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the safety and efficacy of two insulin regimens in Type 2 diabetes patients with moderate renal impairment: insulin glargine plus glu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin glulisine (insulin glulisine)
• NPH insulin (insulin isophane)
• Regular human insulin (human insulin (regular))

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED